Trial intelligence / Profile preview

Tegileridine fumarate injection plus adductor canal block for postoperative analgesia after total knee arthroplasty

ChiCTR2600122439Phase 4Recruiting

Sponsor
Eighth Affiliated Hospital of Sun Yat-sen University
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by Eighth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: NRS pain score (rest and activity). Started Apr 2026; status: recruiting.

02

Drugs

tegileridine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2600122439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600122439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call